NicOx SA  

(Public, EPA:COX)   Watch this stock  
Find more results for MICHELE SPENCE
2.08
+0.02 (1.07%)
Real-time:   11:45AM GMT+2
EPA real-time data - Disclaimer
Currency in EUR
Range 2.06 - 2.13
52 week 1.71 - 2.93
Open 2.07
Vol / Avg. 190,103.00/1.03M
Mkt cap 163.83M
P/E     -
Div/yield     -
EPS -0.33
Shares 72.96M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -613.72% -2429.05%
Operating margin -590.64% -2352.88%
EBITD margin - -2274.16%
Return on average assets -50.46% -23.45%
Return on average equity -58.39% -26.18%
Employees 101 -
CDP Score - -

Address

Drakkar 2 - Batiment D 2405 route des Dolines CS 10313 Sophia Antipolis
VALBONNE, 06560
France
+33-4-97245300 (Phone)
+33-4-97245399 (Fax)

Website links

Description

NicOx SA is a France-based biopharmaceutical company engaged in the research, development and future commercialization of investigational drugs for the treatment of inflammatory, cardio metabolic and ophthalmological diseases. It specializes in the nitric oxide-donating technology. The Company�s main products include Naproxcinod, NCX 116 and NCX 6560. Naproxcinod is a nitric oxide-donating compound, which is used in the treatment of signs and symptoms of osteoarthritis. NCX 116 is a nitric oxide-donating prostaglandin F2-alpha analog developed for the potential treatment of glaucoma (a group of eye diseases). NCX 6560 is a nitric oxide-donating derivative which is used to reduce the risk of cardiac events in heart patients. NicOx SA's other products also include nitric oxide-donating NCEs, developed in partnership with Merck & Co and NCX 1047. The Company offers also Doliage and Carragelose anti-viral eye drop program. In December 2013, it acquired Eupharmed.

Officers and directors

Michele Garufi Chairman of the Board and Chief Executive Officer, Member of the Management Committee
Age: 59
Eric Castaldi Financial Director and Member of the Management Committee
Philippe Masquida Executive Vice President, Managing Director of European Operations and Member of the Management Board
Age: 50
Jerry St. Peter Executive Vice President and General Manager of NicOx Inc, Member of the Management Committee
Age: 45
Pascal Pfister Chief Scientific Officer and Member of the Management Committee
Age: 54
Gavin Spencer Executive Vice President Corporate Development and Member of the Management Committee
Age: 43
Elizabeth Robinson Chairman of NicOx Research Institute Srl and Member of the Management Committee
Age: 57
Vicente Anido Jr.,Ph.D. Director
Age: 51
Jean-Francois Labbe Director
Age: 63
Bengt Samuelsson Director
Age: 78